$31.95 $1.59 per serving
Product analysis
TurmeriPro combines turmeric and bromelain for possible inflammation-related support, with benefits depending on the preparations used. Bromelain and flavonoid costs compare poorly, weakening its value.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality26
The turmeric component is named, while bromelain and flavonoid preparations are unspecified. That leaves their quality and match to preparations with demonstrated benefits uncertain.
Ingredient Transparency75
All ingredient amounts are disclosed. Only turmeric has a named form, making the other preparations harder to compare.
Value For Money29
Bromelain and flavonoids offer weak value in the available comparisons. Turmeric value remains uncertain.
Customer Satisfaction70
Customer ratings are favorable. The very small review pool leaves satisfaction less firmly established.
Product Focus61
The formula is directed toward inflammation-related and digestive support. Evidence for digestive symptom improvement from bromelain alone is limited, and the turmeric extract cannot be assumed to act like turmeric powder.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $1.59
- Customer rating
- 4.7 · 29 ratings
Goals
Impact
Moderate effect
Turmeric at 750 mg and bromelain at 650 mg relate to inflammatory signaling and enzyme-related pathways. Their contribution is qualified by preparation differences: the turmeric is not matched to the named reviewed preparation, and bromelain findings are mixed and specific to particular pain or surgical settings.
How this product is rated for Inflammation
Ingredient fit84
The relevant ingredients give the formula a clear inflammation-related focus. The assessed amounts are mostly aligned with the saved dose comparisons.
Goal fit
The relevant ingredients give the formula a clear inflammation-related focus.
Dose adequacy
The assessed amounts are mostly aligned with the saved dose comparisons.
Pathways41
The strongest assessed connection is to inflammation-related enzyme activity, with moderate coverage in the saved findings. One main mechanism meets the saved coverage threshold; support across the remaining mechanisms is narrower.
Depth
The strongest assessed connection is to inflammation-related enzyme activity, with moderate coverage in the saved findings.
Breadth
One main mechanism meets the saved coverage threshold; support across the remaining mechanisms is narrower.
Evidence48
Turmeric provides the strongest assessed evidence in the formula, with more limited support for this goal. Bromelain matches the saved preparation assessment, while the turmeric preparation remains a weaker match.
Evidence strength
Turmeric provides the strongest assessed evidence in the formula, with more limited support for this goal.
Studied preparation
Bromelain matches the saved preparation assessment, while the turmeric preparation remains a weaker match.
Formulation logic88
All assessed contributors meet the saved minimum amount comparison. No ingredient conflicts were identified in the saved assessment.
Partner coverage
The saved assessment identifies a missing absorption partner for turmeric, limiting its contribution.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
All assessed contributors meet the saved minimum amount comparison.
Impact
Moderate effect
Flavonoid · 112 mgBromelain · 650 mg
Bromelain provides protein-breaking enzyme activity, although evidence for digestive symptom improvement from isolated bromelain remains limited. The turmeric extract cannot be assumed to reproduce the upper-digestive symptom evidence for rhizome powder, and the unspecified flavonoid amount adds little clear support.
How this product is rated for Gut Health
Ingredient fit87
The saved findings show a clear digestive focus within the ingredient mix. The saved amount comparison shows full alignment for the counted ingredients.
Goal fit
The saved findings show a clear digestive focus within the ingredient mix.
Dose adequacy
The saved amount comparison shows full alignment for the counted ingredients.
Pathways60
The main saved coverage is digestive enzyme, acid and bile support, with strong depth. One of the three targeted areas reaches the saved coverage threshold, so support remains narrow.
Depth
The main saved coverage is digestive enzyme, acid and bile support, with strong depth.
Breadth
One of the three targeted areas reaches the saved coverage threshold, so support remains narrow.
Evidence58
Bromelain leads the saved evidence assessment; the ingredient-specific qualifications still apply. The counted ingredients meet the saved preparation comparison, without implying broad symptom relief.
Evidence strength
Bromelain leads the saved evidence assessment; the ingredient-specific qualifications still apply.
Studied preparation
The counted ingredients meet the saved preparation comparison, without implying broad symptom relief.
Formulation logic100
No missing required partners or configured conflicts were flagged, and the counted amounts meet the saved threshold.
Partner coverage
No required ingredient partner is missing in the saved assessment.
Conflicts
No configured ingredient conflict was flagged.
Effective doses
All counted ingredients meet the saved minimum exposure threshold.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Turmeric rhizome (Curcuma longa) powdered extract (Curcuminoids) | 750 mg | |
Bromelain | 650 mg | |
Citrus Bioflavonoids | 112 mg |
Flavonoid · 112 mg OverallScore74
Bromelain · 650 mg OverallScore63
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- The role of enzyme supplementation in digestive disorders.
- Effects of bromelain supplementation on disease activity and quality of life in patients with ulcerative colitis: a randomized, triple-blind, placebo-controlled study.
- Efficacy and Safety of Aurantii Fructus Immaturus Flavonoid Tablets in Patients with Functional Dyspepsia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial.
- Gut enterotype- and body mass index (BMI)-dependent effects of anthocyanin supplementation on gut microbiota composition in individuals at risk for cognitive decline: a randomized placebo-controlled trial.
- Modulation of Microbiota-Derived Bile Acids Linked to Symptom Amelioration in Crohn's Disease: Insights From a Randomized Clinical Trial With Xanthohumol Supplementation.
- The role of the gut microbiome in the association between habitual anthocyanin intake and visceral abdominal fat in population-level analysis.
- The gut microbiome mediates the association between a flavonoid-rich diet and MASLD in a population-level analysis.
- Therapeutic efficacy of bromelain in impacted third molar surgery: a randomized controlled clinical study.
- Efficacy of proteolytic enzyme bromelain on health outcomes after third molar surgery. Systematic review and meta-analysis of randomized clinical trials.
- Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain.
- An Evaluation of the Effects of Pineapple-Extract and Bromelain-Based Treatment after Mandibular Third Molar Surgery: A Randomized Three-Arm Clinical Study.
- Therapeutic uses of pineapple-extracted bromelain in surgical care - A review.